<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht002978.v1" study_id="phs000532.v3" participant_set="1" date_created="Mon Jun 17 11:49:53 2013"><variable id="phv00173800.v1"><name>SUBJID</name><description>CGCI Subject Id</description><type/></variable><variable id="phv00173801.v1"><name>WHO diagnosis</name><description>WHO diagnosis</description><type/><value>COMPOSITE LYMPHOMA</value><value>DLBCL</value></variable><variable id="phv00173802.v1"><name>Days to birth</name><description>Number of days to birth</description><type/><unit>days</unit></variable><variable id="phv00173803.v1"><name>Gender</name><description>Gender</description><type/><value>M</value><value>F</value></variable><variable id="phv00173804.v1"><name>Stage</name><description>Stage (Ann Arbor)</description><type/><value>1A</value><value>1AE</value><value>1B</value><value>1BE</value><value>2A</value><value>2AE</value><value>2B</value><value>2BE</value><value>3A</value><value>3AE</value><value>3B</value><value>3BE</value><value>4A</value><value>4B</value><value>UNKNOWN</value></variable><variable id="phv00173805.v1"><name>Stage group</name><description>Stage (limited vs advanced)</description><type/><value>ADV</value><value>LIM</value></variable><variable id="phv00173806.v1"><name>Performance status</name><description>Performance status (ECOG)</description><type/><value>0</value><value>1</value><value>2</value><value>3</value><value>4</value><value>UNKNOWN</value></variable><variable id="phv00173807.v1"><name>LDH_RATIO</name><description>Lactate dehydrogenase level (LDH) as ratio of measured value/upper limit of normal</description><type/></variable><variable id="phv00173808.v1"><name>Extranodal sites</name><description>Sites of extranodal disease</description><type/><value>adrenal, intestine, pancreas</value><value>adrenal, prostate</value><value>bone</value><value>bone marrow</value><value>bone marrow, peripheral blood</value><value>bone marrow, testicle</value><value>bone marrow, intestine</value><value>Bone marrow, peripheral blood, liver</value><value>Bone marrow, pleura</value><value>bone, soft tissue</value><value>breast</value><value>ENT soft tissue</value><value>Epidural mass, pleura</value><value>intestine</value><value>intestine, liver</value><value>intestine, ureter</value><value>liver</value><value>liver, pancreas</value><value>lung</value><value>lung, peritoneum, pleura</value><value>ovary</value><value>pleura</value><value>salivary gland</value><value>Skin</value><value>soft tissue</value><value>stomach</value><value>stomach, intestine</value><value>testicle</value><value>thyroid</value><value>UNKNOWN</value></variable><variable id="phv00173809.v1"><name>Tumor size</name><description>Largest tumor mass diameter</description><type/><unit>cm</unit></variable><variable id="phv00173810.v1"><name>IPI score</name><description>International prognostic index (IPI) score</description><type/></variable><variable id="phv00173811.v1"><name>Primary treatment</name><description>Primary treatment</description><type/><value>CHOP1</value><value>CHOP1-RITUXIMAB</value><value>CHOP2-RITUXIMAB</value><value>CHOP3-RADIATION</value><value>CHOP3-RITUXIMAB-RADIATION</value><value>CHOP4-RITUXIMAB</value><value>CHOP5-RITUXIMAB</value><value>CHOP6</value><value>CHOP6-RITU</value><value>CHOP6-RITUXIMAB</value><value>CHOP6-RITUXIMAB-intrathecal chemotherapy</value><value>CHOP6-RITUXIMAB-RADIATION</value><value>CHOP6-RITUXIMAB-RITUMAIN</value><value>CHOP6-RITUXIMAB-RITUXIMAB MAINTENANCE</value><value>CHOP6-RITUXIMAB-splenectomy</value><value>CHOP7-RITUXIMAB</value><value>CHOP8</value><value>CHOP8-RITUXIMAB</value><value>CHOP8-RITUXIMAB-oblimersen</value><value>CHOP8-RITUXIMAB-RADIATION</value><value>CHOP-RITUXIMAB</value><value>CHOP-RITUXIMAB-ABVD</value><value>CHOP-RITUXIMAB-RADIATION-splenectomy</value><value>CVP1-RITUXIMAB-CHOP5-RITUXIMAB</value><value>CVP4-RITUXIMAB</value><value>CVP6-RITUXIMAB</value><value>CVP8-RITUXIMAB</value><value>CVPP1-doxorubicin-cyclophosphamide-RITUXIMAB</value><value>CVP-RITUXIMAB</value><value>DOXO-cyclophosphamide-RITUXIMAB</value><value>fludarabine</value><value>FLUD-RITUXIMAB</value><value>OBSE</value><value>prednisone</value><value>RITUXIMAB</value><value>SPLENECTOMY-CHOP6-RITUXIMAB</value><value>UNKNOWN</value></variable><variable id="phv00173812.v1"><name>Days to Primary treatment start</name><description>Number of days to primary treatment start</description><type/><unit>days</unit></variable><variable id="phv00173813.v1"><name>Response</name><description>Response to primary treatment</description><type/><value>COMPLETE</value><value>NONE</value><value>PARTIAL</value><value>PROGRESSION</value><value>UNKNOWN</value></variable><variable id="phv00173814.v1"><name>Days to response assessment</name><description>Number of days to response assessment</description><type/><unit>days</unit></variable><variable id="phv00173815.v1"><name>Days to progression</name><description>Number of days to progressive disease, if occurred</description><type/><unit>days</unit></variable><variable id="phv00173816.v1"><name>Site progression</name><description>Primary site of progression</description><type/><value>abdomen</value><value>abdominal lymph nodes</value><value>bone</value><value>bone marrow</value><value>brain, leptomeninges</value><value>cervical lymph node</value><value>epidural mass</value><value>intestine</value><value>kidney, multiple nodes, brain</value><value>liver</value><value>lung, stomach, multiple lymph nodes</value><value>lymph node</value><value>mediastinal nodes</value><value>mediastinum</value><value>mesenteric lymph nodes</value><value>multiple lymph nodes</value><value>neck lymph nodes</value><value>pelvic lymph nodes</value><value>prostate, testicle</value><value>skin of forehead</value><value>soft tissue</value><value>spleen</value><value>unknown</value></variable><variable id="phv00173817.v1"><name>Secondary treatment</name><description>Secondary treatment</description><type/><value>CHOP3-RITUXIMAB-RADIATION</value><value>CHOP7-radiation, CVP-RITUXIMAB</value><value>CHOP-RITUXIMAB</value><value>CVP8-RITUXIMAB</value><value>dexamethasone, radiation</value><value>DHAP</value><value>etoposide, CVP-RITUXIMAB, radiation</value><value>etoposide, radiation</value><value>FLUD</value><value>FLUDARABINE-RITUXIMAB</value><value>GDP</value><value>GDP, etoposide + dexamethasone</value><value>GDP, radiation, radiation</value><value>GDP,gemcitabine,cyclophosphamide, radiation</value><value>GDP3-RITUXIMAB-ICE</value><value>GDP-HSCT-AUTO</value><value>GDP-HSCT-AUTO-radiation</value><value>GDP-RITUXIMAB-HSCT-AUTO</value><value>NONE</value><value>RADIATION</value><value>radiation, radiation, GDP, ICE</value><value>RITUXIMAB</value><value>SPLENECTOMY-CHOP-RITUXIMAB</value><value>too frail to treat</value><value>unknown</value></variable><variable id="phv00173818.v1"><name>HSCT (yes/no)</name><description>Hematopoietic stem cell transplant (HSCT)</description><type/><value>NO</value><value>YES</value></variable><variable id="phv00173819.v1"><name>Days to HSCT</name><description>Number of days to HSCT</description><type/><unit>days</unit></variable><variable id="phv00173820.v1"><name>Days to transformed lymphoma diagnosed</name><description>Number of days to date transformed lymphoma diagnosed</description><type/><unit>days</unit></variable><variable id="phv00173821.v1"><name>Days to last follow-up</name><description>Number of days to last follow-up</description><type/><unit>days</unit></variable><variable id="phv00173822.v1"><name>Status last follow-up (alive/dead)</name><description>Status at last follow-up</description><type/><value>Alive</value><value>Dead</value></variable><variable id="phv00173823.v1"><name>Cause of death</name><description>Cause of death</description><type/><value>Cerebrovascular disease, unspecified</value><value>DEMENTIA</value><value>HYPERTENSION</value><value>Lymphoma, LARGE CELL(DIFFUSE) DLBC,DLCL</value><value>Lymphoma, unspecified</value></variable><variable id="phv00173824.v1"><name>Cause of death ICD10</name><description>Cause of death ICD10</description><type/><value>C833</value><value>C859</value><value>I679</value><value>M069</value></variable></data_table>
